학술논문
A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial
Document Type
Article
Author
Source
In: International Journal of Gynecological Cancer . (International Journal of Gynecological Cancer, 6 March 2024, 34(4):627-630)
Subject
Language
English
ISSN
15251438
1048891X
1048891X